Floatz logo

N-BUTYL CYANOACRYLATE

Periampullary Cancer

Minia UniversitySmall moleculePhase 3Active
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
52/ 100
Competitive Position
89/ 100

Competitive context

2 Active assets in the Periampullary Cancer cohort.

Asset / SponsorPhaseRating
HUMAN FIBRINOGEN
Asan Medical Center
Phase 4BB
Eloxatin
National Cancer Institute (NCI)
Phase 2B
Cipralex
Case Comprehensive Cancer Center
Phase 2CCC
FLUOROURACILUM
National Cancer Institute (NCI)
Phase 2CCC
Cediranib
National Cancer Institute (NCI)
Phase 2CCC

View all 12 →

Same molecule, other indications

N-BUTYL CYANOACRYLATE is also rated in:

bile duct cancerDormant
B
Indicative ·
60 / 100
View asset →
duodenum cancerDormant
B
Indicative ·
60 / 100
View asset →
cholangiocarcinomaDormant
CCC
Indicative ·
54 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →